Literature DB >> 18407872

Mycotoxic and aristolochic acid theories of the development of endemic nephropathy.

Maja Peraica1, Ana-Marija Domijan, Marko Sarić.   

Abstract

Despite many efforts of scientists and epidemiologists, the aetiology of endemic nephropathy (EN) is still unknown. This disease occurs in the rural population of geographically limited areas of Bulgaria, Bosnia and Herzegovina, Croatia, Romania, and Serbia, and a number of theories have been proposed about its aetiology. The mycotoxin theory has prevailed until now, based on the studies of nephrotoxic mycotoxin ochratoxin A (OTA) that revealed higher frequency of OTA-positive food and blood samples in endemic than in non-endemic areas.However, a new aristolochic acid (AA) theory of EN origin has been proposed recently, due to the histological similarities in kidney lesions between patients suffering from EN and patients suffering from Chinese herbs nephropathy caused by AA. Until now it has not been unequivocally proved that the inhabitants of EN areas are exposed to higher concentration of AA than in other regions and the exposure pathways are rather uncertain. This paper presents most important studies supporting both theories, indicating also the inconsistencies of each.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18407872     DOI: 10.2478/10004-1254-59-2008-1865

Source DB:  PubMed          Journal:  Arh Hig Rada Toksikol        ISSN: 0004-1254            Impact factor:   1.948


  8 in total

1.  Analyses of biomarkers of exposure to nephrotoxic mycotoxins in a cohort of patients with renal tumours.

Authors:  Frantisek Malir; Miroslav Louda; Vladimir Ostry; Jakub Toman; Nurshad Ali; Yann Grosse; Eva Malirova; Jaroslav Pacovsky; Darina Pickova; Milos Brodak; Annie Pfohl-Leszkowicz; Gisela H Degen
Journal:  Mycotoxin Res       Date:  2019-06-29       Impact factor: 3.833

2.  A comparison between the effects of ochratoxin A and aristolochic acid on the inflammation and oxidative stress in the liver and kidney of weanling piglets.

Authors:  D E Marin; G C Pistol; M Gras; M Palade; I Taranu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-22       Impact factor: 3.000

3.  Ochratoxin A in human blood serum - retrospective long-term data.

Authors:  Erwin Märtlbauer; Ewald Usleber; Richard Dietrich; Elisabeth Schneider
Journal:  Mycotoxin Res       Date:  2009-09-15       Impact factor: 3.833

Review 4.  The involvement of mycotoxins in the development of endemic nephropathy.

Authors:  Maja Peraica; Ana-Marija Domijan; Marica Miletić-Medved; Radovan Fuchs
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 5.  «Suspects» in etiology of endemic nephropathy: aristolochic acid versus mycotoxins.

Authors:  Stjepan Pepeljnjak; Maja Šegvić Klarić
Journal:  Toxins (Basel)       Date:  2010-06-11       Impact factor: 4.546

6.  Development and characterization of a monoclonal antibody against Ochratoxin B and its application in ELISA.

Authors:  Alexandra H Heussner; Simon Ausländer; Daniel R Dietrich
Journal:  Toxins (Basel)       Date:  2010-06-21       Impact factor: 4.546

Review 7.  Ochratoxins-food contaminants: impact on human health.

Authors:  Lalini Reddy; Kanti Bhoola
Journal:  Toxins (Basel)       Date:  2010-04-20       Impact factor: 4.546

8.  Offspring of parents with Balkan Endemic Nephropathy have higher C-reactive protein levels suggestive of inflammatory processes: a longitudinal study.

Authors:  Wilfried Karmaus; Plamen Dimitrov; Valeri Simeonov; Svetla Tsolova; Vecihi Batuman
Journal:  BMC Nephrol       Date:  2009-04-28       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.